Core Viewpoint - Nutex Health Inc. has announced an extension of its stock repurchase program, reflecting the Board's confidence in the company's long-term strategy and commitment to enhancing shareholder value [1][5]. Group 1: Stock Repurchase Program - The original stock repurchase program, announced on August 14, 2025, authorized the repurchase of up to $25.0 million of common stock over a six-month period starting from the filing of the Form 10-Q for the quarter ended June 30, 2025 [2]. - The program has been extended through March 31, 2026, and will be implemented under Rule 10b-18 and a Rule 10b5-1 trading plan, effective around December 4, 2025 [3]. - The purpose of the share repurchase program is to increase shareholder value and offset dilution from additional shares related to stock compensation obligations for under-construction and ramping hospitals [4]. Group 2: Company Overview - Nutex Health Inc., headquartered in Houston, Texas, was founded in 2011 and operates as a healthcare management and operations company with two divisions: Hospital Division and Population Health Management Division [6]. - The Hospital Division owns and operates 25 facilities across 11 states, focusing on innovative healthcare models, including micro-hospitals and specialty hospitals [6]. - The Population Health Management Division operates provider networks such as Independent Physician Associations and provides management and administrative support services to affiliated hospitals and physician groups [7].
NUTEX HEALTH EXTENDS SHARE REPURCHASE PLAN